default author photo

Caroline Atyeo

Ragon Institute of MGH, MIT and Harvard

Boston, MA

United States

SCHOLARLY PAPERS

4

DOWNLOADS

170

TOTAL CITATIONS

5

Scholarly Papers (4)

1.

Therapeutic Potential of SARS-CoV-2-Specific Monoclonal Antibody CR3022

Number of pages: 15 Posted: 01 Jun 2020
Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Boston University - Department of Microbiology, Xencor, SeromYx Systems, SeromYx Systems, Boston University - Department of Microbiology, Xencor, Ragon Institute of MGH, MIT and Harvard, Harvard University - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology and Ragon Institute of MGH, MIT and Harvard
Downloads 62 (942,565)
Citation 1

Abstract:

Loading...

SARS-CoV-2, antibody effector function, immunity, Fc function, CR3022

2.

A Fc-Engineering Approach to Define Functional Humoral Correlates of Immunity Against Ebola Virus

Number of pages: 50 Posted: 16 Jun 2020
Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, University of Texas Medical Branch-Galveston - Department of Pathology, University of Texas Medical Branch-Galveston - Department of Pathology, Ragon Institute of MGH, MIT and Harvard, La Jolla Institute for Allergy and Immunology (LIAI), Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Hokkaido University - Division of Global Epidemiology, University of Wisconsin - Madison - Department of Pathobiological Sciences, University of Wisconsin - Madison - Influenza Research Institute, Scripps Research Institute - Department of Immunology and Microbiology, Kenema Government Hospital - Viral Hemorrhagic Fever Program, Kenema Government Hospital - Viral Hemorrhagic Fever Program, Kenema Government Hospital - Viral Hemorrhagic Fever Program, The Scripps Research Institute - Department of Immunology and Microbiology, Tulane University - Department of Pediatrics, Kenema Government Hospital - Viral Hemorrhagic Fever Program, Tulane University - Department of Microbiology and Immunology, La Jolla Institute for Allergy and Immunology (LIAI), University of Texas Medical Branch-Galveston - Department of Pathology and Ragon Institute of MGH, MIT and Harvard
Downloads 40 (1,183,237)
Citation 3

Abstract:

Loading...

Antibody engineering, Ebola virus, Fc effector function

3.

Antibody Transfer via Breastmilk After SARS-CoV-2 Infection

Number of pages: 34 Posted: 13 May 2021
Massachusetts Institute of Technology - Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Harvard Medical School - Beth Israel Deaconess Medical Center, Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School - Brigham and Women's Hospital, Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School - Brigham and Women's Hospital, Department of Pediatric Newborn Medicine, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Harvard University - Department of Obstetrics, Gynecology and Reproductive Biology and MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard
Downloads 37 (1,222,651)

Abstract:

Loading...

COVID-19, breastmilk, pregnancy, antibody transfer, Fc-receptor

4.

Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ Vaccination

Number of pages: 41 Posted: 06 Apr 2021
Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Massachusetts Institute of Technology - Department of Biological Engineering, Ragon Institute of MGH, MIT and Harvard, Texas Biomedical Research Institute, Texas Biomedical Research Institute, Novavax, Inc., Ragon Institute of MGH, MIT and Harvard, Ragon Institute of MGH, MIT and Harvard, Novavax, Inc., Novavax, Inc., University of Maryland - School of Medicine, University of Maryland - School of Medicine, University of Maryland - School of Medicine, Duke University - Duke Human Vaccine Institute, La Jolla Institute for Allergy and Immunology (LIAI), La Jolla Institute for Allergy and Immunology (LIAI), Icahn School of Medicine at Mount Sinai - Department of Microbiology, Icahn School of Medicine at Mount Sinai - Department of Microbiology, La Jolla Institute for Allergy and Immunology (LIAI) - Center for Infectious Disease and Vaccine Research, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc., Novavax, Inc. and MassachusettsGeneral Hospital - Ragon Institute of MGH, MIT and Harvard
Downloads 31 (1,304,549)
Citation 1

Abstract:

Loading...

NVX-CoV2373 vaccine, Matrix-M™ adjuvant, SARS-CoV-2 spike glycoprotein, non-human primate, COVID-19